The observation that viruses may exhibit different biological properties when maintained in different hosts is well established. Because of its practical consequences the phenomenon of reduced virulence has been the subject of numerous studies. However, owing to the complexity of host-virus interactions, basic information is still scanty (1), and it is mainly for this reason that use of attenuated variants for active immunization has been greatly hampered, the possibility of reversion to virulence being of great concern. The more recent finding that polioviruses may become attenuated for their original primate host when passed in cells in vitro (2, 3) has once more stimulated attempts to obtain insight into the basic mechanisms governing the appearance and selection of attenuated variants.
ADAPTATION OF COXSACKIE VIRUSES TO HlbWIAN AMNION CELLS
a final concentration of 0.11 per cent. Penicillin, streptomycin, and tetracycline were added to give 100 units, 100/zg. and 25/zg. per ml., respectively. Monkey kidney (MoK) cell cultures were prepared as described by Rappaport (8) . Growth medium consisted of 0.5 per cent LaH in BSS with 5 per cent CaS (9) . After inoculation, ceils were maintained under a similar medium with CaS reduced to 1 to 2 per cent and NaHCO3 (added as a 1.4 per cent solution in water) increased to a final concentration of 0.14 per cent.
Suckling Mice.--Litters from Swiss albino mothers were used when 12 to 36 hours old.
Viruses.--Coxsackie group A viruses had had a history of passages in newborn mice only. We are indebted to Dr. G. Dalldorf for strains "Belgium l" (A-11), "Floras" (A-13), "G 14"
(A-14), "G 9" (A-15), and "G 13" (A-18). From Dr. J. L. Melnick we received "Wiederhold" (A-9) and "Alaska" (A-10). Pools of group A viruses were prepared in suckling mice. After intraperitoneal injection of 0.05 ml. of mouse suspension containing 100 to 1000 LD~0 the animals were killed with ether when extensive paralysis had developed. They were skinned, eviscerated, and ground with alundum in a mortar. A 1:10 suspension (w/v) was prepared with BSS containing 10 per cent inactivated CaS and antibiotics. After centrifugation the supernate was stored in ampoules at --30°C. This virus source was considered 10 -1 for further calculations. When this study was initiated only Coxsackie B viruses, which had previously been passed in HeLa and MoK ceils, were available. "Connecticut-5" (B-I) had been passed 17 times in HeLa and once in MoK cells before a working pool from MoK cell cultures was prepared. "Ohio 1" (B-2) had had a history of 8 HeLa and 8 MoK passages, "Nancy" (B-3) of 12 HeLa passages, and "Powers" (B-4) of 14 HeLa and 6 MoK passages before a final MoK pool was prepared. "Faulkner" (B-5) had been maintained in HeLa and MoK (3 and 1 passages, respectively) prior to pool production. These viruses had come to our laboratory originally from Dr. A. B. Sabin (B-2 and B-4), Dr. J. L. Melnick (B-3), Dr. G. Dalldorf (B-5), and from the American Type Culture Collection (B-I). Pools from MoK cultures were prepared as follows: monolayer cultures in 200 ml. bottles were infected with high doses of virus. After almost complete cell destruction, cells and medium were frozen and thawed once, centrifuged, and stored in ampoules at -30°C. For calculations this material was considered to be undiluted (10°C.).
Through the kind help of Dr. J. L. Melnick, Dr. A. B. Sabin, and Dr. L. Rosen it later became possible to include the same Coxsackie group B strains without any cell culture history. Pools as l0 per cent mouse suspension were prepared as with group A viruses, except that the intracerebral route of inoculation (0.02 ml.) was employed.
Passages.--For high concentration passages, between 100 and 10,000 TCID~0 were inoculated into tube cultures. Mter extensive cytopathic effect (CPE) had developed, cells and medium were frozen and thawed once, pooled, and used for further passage under similar conditions. For high dilution passages, cultures were infected as for titration. All tubes of the highest dilution showing CPE were frozen and thawed once and the pooled contents were used for the next passage.
Back passages in mice were done at high concentration only. In the case of group A viruses 0.05 ml. of a 10 per cent virus suspension was inoculated intraperitoneally into each of 6 to 8 mice. Animals were killed when paralysis was extensive or by the 5th day if no symptoms developed. A 10 per cent suspension from at least 4 mice was prepared and used for further passage. The procedure for group B viruses was essentially the same except that 0.02 ml.
were inoculated intracerebrally and 0.05 ml. were inoculated intraperitoneaUy.
Clonal Sdection of Viruses.--Although most of the Coxsackie viruses used in this study produced a marked CPE on amnion cells under a liquid medium, A-10, A-11, A-13, A-14, A-15, and A-18 and B-2 and B-4 developed plaques under agar irregularly and of pin-point size only. Therefore, purification was attempted by limiting dilution procedure. 5 to 6 tubes per tenfold dilution step were inoculated. Cultures showing CPE were frozen at --20°C. At the end of the observation period of 8 days the content of a single tube from a dilution at least 1 step above the calculated TCIDs0 was used for further passages in the same manner. Since some of the Coxsackie viruses produce little CPE with low virus concentrations even after prolonged observation periods (10), end points are not always sharp and might well he underestimated. That this imposes serious limitations on purification procedures based on the limiting dilution principle is obvious. No other approach, however, was available. Types A-9 and B-3 were also plaque-purified. Virus diluted in 0.5 log steps was spread on cell monolayers in square screw cap bottles. Mter 2 hours' adsorption, cultures were rinsed 3 times with 5 ml. BSS and overlaid with a medium containing 0.75 per cent agar. After 36 to 48 hours a second overlay with neutral red 1 : 10,000 was added. Discrete plaques from bottles containing only 1 to 3 plaques were picked with a bent pipette, transferred to 1 ml. BSS, and frozen and thawed once. Mter filtration through a membrane filter (Mlllipore type HA) this suspension was again diluted and directly transferred onto new monolayers for further plaque passage.
Virus Titrations.--6 tube cell cultures per tenfold serial dilution of virus were used. Virus was diluted in maintenance medium and inoculated in 1 ml. amounts into cultures. All final readings were done on the 9th day. Titrations in suckling mice were performed by inoculating 0.05 ml. intraperitoneally or 0.02 ml. intracerebrally for group A and B virus respectively into at least 8 mice per tenfold dilution step. All mice dead between the 4th and 14th day were considered positive. The titers were calculated according to Behrens (11) and Reed and Muench (12) , and expressed on a 1 ml., 0.05 ml., and 0.02 ml. basis for titrations done in cell cultures and mice, group A and group B, respectively. Passages in amnion cell cultures resulted in a marked attenuation of the viruses for mice, associated with a significant flattening of the dose-response curve. Accordingly attenuated viruses were titrated in duplicate or triplicate to compensate for loss of accuracy.
Virus Neutralization Tezts.--Monkey immune sera, previously prepared in our laboratory and tested by Dr. R. L. Crowell of this department, diluted 1: 20 in maintenance medium, were added to an equal volume of virus suspension diluted to contain approximately 200 TCID~0/ ml. Mter 1 hour of incubation at 37°C., 1 ml. of this mixture was added to each of 6 tissue culture tubes. The final reading was done on the 9th day. Appropriate controls were included to ensure the correct amount of the challenging virus.
Deflnitions.--"Adaptation" is used to indicate increase in titer and degree of cell destruction and a decrease in time of appearance of CPE in the course of passage of the virus in cell cultures. "Attenuation" or "loss of virulence" denotes decrease of pathogenicity of the virus for mice when control titrations in cell cultures fail to show a corresponding drop of titer.
EXPERIMENTAL
Adaptation to Human Amnion Cells in Primary Culture.--From the 24 Coxsackie p r o t o t y p e viruses tested in h u m a n a m n i o n cells in vitro, A-9, A-10, A-11, A-13, A-14, A-15, and A-18 and B-1 to B-5 could be passed with C P E (10). Continuous high concentration passage of these 7 group A and 5 group B strains resulted in increase in infectious titer and proportion of cells destroyed and a decrease in time for the appearance of C P E . A l t h o u g h these observations were unequivocal, definite conclusions as to the degree of a d a p t a t i o n could not be drawn from the results. Therefore an experiment was done in which 1st and 10th a m n i o n passage viruses were c o m p a r e d under more controlled conditions.
Cultures were prepared from a single placenta. They were inoculated with the original mouse or monkey kidney virus and with the 9th amnion passage virus of types A-9, A-11, A-13, A-15, A-18, B-l, B-2, B-3, and B-5. An attempt was made to use equal infectious doses for both passage levels. The 10th passage cultures showed cell destruction faster and more extensively than those of the 1st passage. This phenomenon was particularly striking in the case of the group A viruses which will be considered first. Comparative titrations of the 1st and 10th passage pools prepared as described were performed using tube cultures from ! placenta.
Results are shown in Table I . It can be seen that in all cases the 10th passage titers exceeded those of the 1st passages. The differences were marked in most cases and left no doubt as to their significance. Since A-10 and A-14 showed no CPE with 1st amnion passage, they were not included in the comparative Cultures from a single placenta were inoculated with original mouse virus and 9th amnion passage virus. Comparative titrations of 1st and 10th passage pools thus obtained were performed in mice and in tube cultures from 1 amnion.
* Negative log LDs0 per 0.05 ml. and TCIDso per 1 ml., respectively.
assay just described. The extent of adaptation can, however, be assessed from Table I I which shows significant increase of infectious titers with successive amnion passages. The group B viruses showed little, if any, adaptation when 1st and 10th amnion passage of viruses previously maintained in cell cultures were compared by amnion cell assay. When reference is made to viruses without in vitro history, adaptation with continuous passages in cell cultures of primate origin appears to be very pronounced (Table III) . Only the " N a n c y " strain of B-3 virus exerted extensive cell destruction with high titers from the beginning and did not change this property with passages in ceils.
Attenuation of Virulence for Newborn M i c e . --W h e n comparable virus preparations from 2 separate culture passages were titrated in mice it was seen that the gain in infectivity for ceils in vitro was associated with a decreased pathogenicity for mice (Table I ). Attenuation was most obvious with types A-11 and A-15. Here the inoculation of more than 10,000 TCIDs0 caused the The stored virus from amnion passages 1, 10, and 15 together with the original material was titrated in mice and in tube cultures from human amniotic membranes.
* Negative log LDs0 per 0.05 ml. and TCIDs0 per 1 ml., respectively. n.d., not done. Monkey kidney prepared viruses after passages in HeLa and monkey kidney cells and amnion prepared viruses after 1, 10, and 15 passages in amnion cells together with original mouse passage virus were titrated in mice and in tube cultures from human amniotic membranes.
TABLE III

Comparative Titrations in Amnion Cell Cultures and in Suckling Mice of Coxsackie B Virus Strains after Passages in Cell Cultures
* Negative log LDs0 per 0.02 ml. and TCIDs0 per 1 ml. :~ n.d., not done.
death of less than 50 per cent of the mice. The most conspicuous finding in the surviving animals was their retarded growth compared with the control litter mates. Only some of the mice appeared sick, and occasionally mild paralysis could be observed. Suckling mice infected with undiluted 10th amnion passage virus of Coxsackie A-11 and A-15 showed histologically isolated focal areas of muscle destruction as described by Gifford and Dalldorf (13) . In order to gain some insight into the kinetics of this attenuation the following experiments were performed.
Five additional high concentration passages were carried out in amnion cells. The stored suspensions from amnion passages 0 to 6, 8, 10, and 15 of A-11, A-13, A-15, and A-18 were titrated in suckling mice and also in arnnion cell cultures. For A-9, A-10, and A-14 only passage numbers 0, 1, 10, and 15 were similarly titrated in both host systems.
The results are presented in Fig. 1 and Table II . Kinetics of attenuation seem to be similar for all viruses tested. The speed, however, with which the lowest levels of virulence for mice were reached differed from virus to virus. With some strains attenuation progressed so fast that it became doubtful whether virus which was still virulent for mice had multiplied at all in amnion. Inactivation rates of these viruses at 37°C. in cell culture medium were determined (14) . Calculated titers based on thermal inactivation and dilution are included in Fig. 1 . A significant gap between titers thus expected and titers observed indicates that multiplication of mouse virulent viruses in amnion took place. Results with group B viruses treated in the same manner are given in Table III A-15, B-I, B-2, and B-5 were passed further in mice which led to an additional increase of virulence (Fig. 5 ). When these materials were also titrated in human amnion cell cultures it was found that, irrespective of low or increased virulence for mice, large amounts of amnion pathogenic viruses were produced in vivo at each passage level (Fig. 5) In addition to the 15 high concentration passages, 5 high dilution passages followed by 4 limiting dilution passages were performed as described under Methods. Production of final (25th amnion passage) pools was done by inoculating approximately 10 TCIDs0 per ml. into bottle cultures. A-9 and B-3 were also 3 times plaque-purified after 15 passages at high concentration, final pools being prepared as for limiting dilution purification.
Comparative titrations of these purified viruses in amnion cells and in suckling mice indicated further attenuation of most viruses (see Figs. 6 and 7) . After triple plaque purifications, as compared with limiting dilution procedure, A-9 appeared to be more attenuated. Neither limiting dilution nor picking of plaques significantly changed the original properties of B-3.
Stability of attenuation after purification was tested with A-9 (plaquepurified) and A-11, A-13, and A-15 viruses. In contrast to the results obtained after high concentration passages only (see Fig. 3 ) purified viruses shared a degree of stability (Fig. 8 ) similar to that seen before with B-I, B-2, and B-5. It is noteworthy that limiting dilution procedure markedly increased the stability of A-15 which had shown slow reversion to virulence after high con- disease (19, 20) , Teschen disease of swine (21), West Nile virus (22) , Col SK strain of the encephalomyocarditis group (23) , and the 3 types of polioviruses (24) are examples. Attenuated variants of certain Coxsackie strains have also been obtained (25) (26) (27) (28) . Continuous passages of Coxsackie prototype strains in human amnion cells resulted in increase in infectious titer and degree of cell destruction, and a decrease in time for the appearance of CPE in 11 out of 12 strains. This gain in infectivity was in all cases associated with a decreased pathogenicity for mice. The speed with which some strains became attenuated is remarkable (Fig. 1 ). Yet in most cases 15 passages employing large inocula did not lead to any degree of genetic stability. Although the course of adaptation and attenuation of Coxsackie viruses after passages in cells of primate origin can readily be recognized from our results not much can be said about the underlying principles which are operative. It is likely that a genetic mechanism is involved. The only alternative, namely a host-induced change which has been shown to occur with bacterial viruses (29, 30) and possibly with animal viruses (31, 32) should lead to phenotypic changes only. The possibility of a host-induced change which is ultimately genotypic (33) cannot, however, be ruled out. It must also be assumed that adaptation of Coxsackie viruses to cells in vitro and attenuation to mice occur--with the possible exception of B-2--independently of each other. Reversion to mouse virulence did not as a rule lead to a corresponding drop of pathogenicity for cells in vitro. There can be little doubt that the change in virulence of Coxsackie viruses after passages in cells of primate origin is due to a qualitative alteration of the virus particles. The other possible explanation is that a large proportion of amnion infective virus is completely avirulent for mice and that the comparatively low titers in vivo are due to a small number of fully virulent mouse particles. The flattened dose-response curves as obtained with all attenuated variants strongly points towards a qualitative change (34) . That interference due to some factor produced in amnion cells is operative in mice only is unlikely because attenuated variants maintained their properties over several back passages in mice. Furthermore, a limited number of experiments did not indicate any ability of attenuated virus produced in amnion to interfere with the fully virulent original agent in mice (14) .
The following hypothesis seems to explain adequately most of the observations. The virus as it is passed and propagated in suckling mice is pathogefiic for mice and to a much lesser degree for certain cells in culture. Mutations leading to a variant with decreased mouse pathogenicity, and increased effect on cells in culture, occur at a high rate. This variant which is at a competitive disadvantage in mice outgrows the original type in cells in vitro.
No explanation can be offered for the genetic instability of attenuated viruses which must be inferred from the gradual reversion to virulence~even after purifying procedures--upon back passage in mice. Burnet and Lind (35) found a similar phenomenon with influenza virus. Dulbecco and Vogt, when studying the stability of poliovirus mutants which had a low plating efficiency under acid agar, found likewise a stepwise reversion towards the original wild type (36) . It is also well known that attenuated polioviruses, even after purification procedures, can revert to increased neurovirulence following multiplication in man (37, 38) or when passed in human cells in culture (39) .
The reduced pathogenicity of the viruses for mice in spite of unaltered ability to multiply is also unexplained as yet. It could be a change of tissue tropism with shift of multiplication to organs not essential for survival. It also could be due to a reduced speed of multiplication in vivo, thus permitting the mouse to reach a certain critical age beyond which even maximal amounts of virus do not cause overt paralysis, as was found by Eggers and Sabin with ECHO 9 after passage in monkey kidney cells in culture (40) . Experiments are now planned to obtain more information about the action of attenuated Coxsackie viruses in mice.
In view of the recent discussion in the literature concerning classification of the group of enteroviruses, our findings are significant. It seems that any classification based solely or mainly on the host spectrum of the agent can lead to conclusions not always justified, if its previous history--in nature or in the laboratory--can be suspected to have altered the host spectrum. It is possible that some of the Coxsackie viruses, if tested in mice after isolation and p~ssages in cell culture, would have been classified as ECHO types. A similar confusion might have resulted as it now exists with ECHO 9, whose unexpected mouse pathogenicity led to attempts to reclassify the Coxsackie and ECHO viruses (41, 42) . Probably for such reasons, in the discussions on nomenclature at the Fifth International Congress of Microbiology held in 1950 at Rio de Janeiro, there was "unanimous" opinion that "symptoms produced in the host should, with emphasis, be placed at the bottom" of the list of criteria to be applied in classifying viruses (43) .
SUMMARY
Continuous passages in primary human amnion cell cultures of Coxsackie prototype viruses A-9, A-10, A-11, A-13, A-14, A-15, A-18, B-l, B-2, B-4, and B-5 increased the titers, hastened and enhanced cytopathic effect, and in varying degrees caused loss of virulence for newborn mice. Only B-3 behaved differently in that neither adaptation to cells in vitro nor attenuation with respect to the original animal host could be observed. Types A-15, B-l, B-2, and B-5 slowly regained virulence when passed in mice after high concentration passages in amnion cells whereas all other viruses reverted to their original virulence after only 1 or 2 passages in the animal host. When these strains, however, were purified by cloning procedures, they too showed markedly increased stability. In all stages of attenuation, viruses multiplied extensively in vivo as could be shown by titration in amnion cell cultures. It is suggested that a genetic mechanism is operative leading to virus populations in which the majority of the particles is qualitatively changed. 
